36 results
8-K
EX-1.1
SYRS
Syros Pharmaceuticals Inc.
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
), the Company had prepared the following information (collectively with the pricing information set forth on Annex A, the “Pricing Disclosure Package … the Securities, on the terms set forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriters may offer
424B3
xrqxg62jv xtmb
8 Aug 22
Prospectus supplement
5:47pm
S-4
h26g ygmipvzssq
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
8-K
EX-1.1
mdblp
20 Jan 21
Syros Announces Proposed Offering of Common Stock
4:04pm
8-K
EX-2.1
qyv6kxra3xvsbma096ma
7 Dec 20
Entry into a Material Definitive Agreement
6:05am